Hero Image

Stem Cell Therapy for Knees: Benefits, Risks & Options

Stem cell therapy for knees is one of the most talked-about options for knee pain today.

In this plain-English guide, you’ll learn what it is, how it’s used, who may benefit, where to seek treatment, how it stacks up against other options, and the questions to ask before you decide.

What is stem cell therapy for knees?

In knee care, “stem cell therapy” usually refers to injecting cells or cell-rich preparations into the joint to reduce pain and improve function. Most clinical offerings use mesenchymal stromal cells (MSCs) from your own bone marrow or fat, prepared at the bedside and then injected with image guidance. Major centers like the Cleveland Clinic describe it as an emerging option for knee osteoarthritis (OA) and certain injuries, typically considered after standard therapies.

It’s important to understand the regulatory status. In the U.S., the FDA warns that many marketed “stem cell” products are unapproved and have not been proven safe or effective for orthopedic conditions. Autologous, minimally manipulated procedures may be offered in some settings, but cultured cells and most birth-tissue products (like amniotic fluid) are not FDA-approved for knee arthritis outside research.

Despite the name, today’s injections are not magic cartilage replacements. The primary goal is to modulate inflammation and support the joint environment; any cartilage effects are still being studied. This distinguishes them from platelet-rich plasma (PRP), which concentrates platelets and growth factors but does not include stem cells.

How does it work?

MSCs are thought to help mostly through paracrine (signaling) effects—releasing anti-inflammatory and trophic factors that may quiet pain pathways and support tissue homeostasis. Some lab and early clinical studies suggest improvements in pain and function for knee OA over 6–24 months, but imaging evidence of cartilage regrowth is mixed. Reputable overviews from academic sources, such as Harvard Health, stress that results vary and more high-quality trials are needed.

If you’re curious about ongoing research, browse registered studies on ClinicalTrials.gov. Look for randomized controlled trials in knee osteoarthritis or focal cartilage defects and note whether they use bone marrow–derived, adipose-derived, or culture-expanded cells.

Who might be a candidate?

Stem cell therapy is most often considered for adults with mild-to-moderate knee osteoarthritis who have persistent pain and stiffness despite exercise therapy, weight management, oral/topical medications, and possibly injections like corticosteroids, hyaluronic acid, or PRP. Candidates should be able to participate in rehab and activity modification after the procedure.

It’s not ideal for everyone. People with advanced “bone-on-bone” arthritis may see limited benefit compared to joint replacement. Contraindications can include active infection, certain blood or immune disorders, poorly controlled diabetes, and use of immunosuppressive therapies—your specialist will review risks based on your health history.

Professional societies urge caution. The American College of Rheumatology’s OA guidance emphasizes that orthobiologics like stem cells should generally be limited to research or carefully selected cases because evidence is still evolving (ACR guideline hub).

What the procedure is like

Protocols vary by clinic, but a typical autologous approach involves: (1) harvesting bone marrow from the pelvis or fat from the abdomen/flank; (2) processing the sample to concentrate cells; and (3) injecting the prepared concentrate into the knee under ultrasound or fluoroscopic guidance. Image guidance helps place the injectate accurately in the joint or around structures such as the meniscus or ligaments—see an overview of ultrasound-guided injections from Hospital for Special Surgery.

The visit is usually outpatient, with local anesthesia and sometimes light sedation. Expect temporary soreness at harvest and injection sites. Many clinicians pair the injection with a targeted rehab plan over several weeks.

Benefits you might (and might not) expect

Potential benefits reported in studies and clinical practice include reduced pain, improved function (walking tolerance, activities of daily living), and lower reliance on NSAIDs or steroid injections for several months to a couple of years. Some small randomized trials report patient-reported outcome improvements versus placebo or hyaluronic acid, though not universally.

Limitations include variable response, uncertain durability beyond 12–24 months, and inconsistent structural (MRI) changes. Results appear less robust with severe joint-space narrowing. No therapy can guarantee cartilage regrowth or full return to high-impact sports.

Risks and side effects

Common, usually short-lived issues include post-injection flare, swelling, and stiffness. Less common but serious risks include infection, bleeding, nerve injury, or reaction to anesthetics. Procedures involving tissue harvest add donor-site pain or bruising. Because products and methods differ, risk profiles vary—see the FDA’s consumer advisory on regenerative medicine safety. Adverse events can be reported through the FDA’s MedWatch program.

How it compares to other knee treatments

Conservative care

  • Exercise + physical therapy: Cornerstone for OA; improves pain, strength, and function. Start here and keep doing it regardless of other treatments (ChoosePT guide).
  • Weight management: Even 5–10% loss can significantly reduce knee load and pain (CDC OA overview).
  • Medications: Topical/oral NSAIDs, acetaminophen, and short courses of duloxetine or tramadol in select cases under medical guidance.

Injections

  • Corticosteroids: Widely used for short-term pain relief; repeated use may have downsides in cartilage health—best reserved for flares.
  • Hyaluronic acid (viscosupplementation): Mixed evidence; some patients report relief for months, others do not (AAOS overview).
  • PRP: Uses your platelets to modulate inflammation; growing evidence for mild-to-moderate OA, typically lower cost than stem cell procedures (Mayo Clinic PRP).
  • Stem cell therapy: May help selected patients, but evidence is still maturing and protocols aren’t standardized.

Procedures and surgery

  • Radiofrequency ablation (genicular nerves): Can provide 6–12+ months of pain relief for some with OA pain (Cleveland Clinic).
  • Osteotomy or cartilage procedures: For selected younger, active patients with malalignment or focal defects.
  • Total knee replacement (TKA): Highly effective for end-stage OA when function is severely limited (AAOS TKA).

Professional guidelines such as the ACR and NICE OA guideline generally prioritize lifestyle therapy, PT, medications, and selective injections before considering surgery. Stem cell therapy currently sits as an option for highly selected patients or in research settings.

Where to get treatment (and how to choose a clinic)

Prioritize board-certified specialists in sports medicine, physical medicine & rehabilitation, or orthopedic surgery—ideally at an academic or hospital-affiliated center. Ask whether the clinic participates in registries or clinical trials and whether it uses ultrasound or fluoroscopic guidance for all injections.

Verify regulatory compliance and transparency. Avoid clinics that promise guaranteed regrowth, use cultured cells outside an approved trial, or won’t disclose the exact product, cell source, and processing. The FDA offers guidance on identifying legitimate offerings and reporting concerns (FDA consumer update). You can also explore active studies at ClinicalTrials.gov.

Look for clinics that provide written informed consent, realistic expectations, and a structured rehab plan. Many reputable programs will first optimize exercise therapy, weight, and other modifiable factors.

Costs, coverage, and practicalities

In the U.S., stem cell injections for knee OA are typically cash-pay. Prices often range from roughly $2,000–$6,000 per knee depending on harvest method, processing, and clinic expertise. Insurance coverage is uncommon outside clinical trials. Be wary of high-pressure sales, prepaid packages, or add-ons without clear benefit.

Ask for an itemized estimate that clarifies harvesting, processing, imaging guidance, facility fees, sedation (if any), and follow-up visits. Confirm the provider’s emergency coverage and infection-prevention protocols.

Questions to ask before you proceed

  • What knee diagnosis do I have, and what evidence supports stem cell therapy for my specific case?
  • What cell source do you use (bone marrow vs fat), and why?
  • How many injections, what dose/volume, and will you use image guidance?
  • What outcomes do your patients typically see at 3, 6, and 12 months? Do you track results in a registry?
  • What are the risks in my situation, and how will you manage complications?
  • What’s the total cost, and what is your refund or retreatment policy if I don’t improve?
  • What alternatives should I try first (PT, weight loss, PRP, RFA, surgery), and when would you recommend them?

Bottom line

Stem cell therapy for knees may reduce pain and improve function in carefully selected patients, but it’s not a guaranteed fix and remains an evolving area of care. Start with proven fundamentals—exercise therapy, weight management, and guideline-based care—and consider stem cells in consultation with a specialist at a reputable, compliant center. For more background on knee OA itself, see the AAOS overview and the AAPM&R position statement on regenerative medicine.